Cyfendus
This webpage contains information on Cyfendus, a two-dose anthrax vaccine approved by FDA in 2023 for use after suspected or confirmed exposure to anthrax.
Favorite:
Login to rate, favorite, and comments
on the article
Comments
0
Toggle Open/Close
You must Login to add a comment
- This item doesn't have any comments